EU CHMP recommends approval of Olaparib/Abiraterone for first-line mCRPC treatment - Surprising as OS results are still immature. @AzadOncology @ResearchWyatt @urotoday @alkretsc_urol @drsfrees @PGrivasMDPhD
astrazeneca.com/media-centre/p…
www.astrazeneca.com Lynparza in combination with abiraterone recommended for approval in the EU by CHMP as 1st-line... astrazeneca.com/media-centre/p…